Autoantibodies

Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage
Thomas McDonnell, Raj Amarnani, Carina Spicer, Hajar Jbari, Charis Pericleous, Valentina A Spiteri, Chris Wincup, Bahar Artim-Esen, Ian Mackie, Marina Botto, Anisur Rahman, Ian Giles

Lupus Science & Medicine Aug 2022, 9 (1) e000738; DOI: 10.1136/lupus-2022-000738
Immune complex–driven neutrophil activation and BAFF release: a link to B cell responses in SLE
Ting Wang, Andrew Vasconcellos, John Marken, Sladjana Skopelja-Gardner, Christian Lood, Natalia V Giltiay

Lupus Science & Medicine Jul 2022, 9 (1) e000709; DOI: 10.1136/lupus-2022-000709
Role of autoantibodies and blood–brain barrier leakage in cognitive impairment in systemic lupus erythematosus
John G Hanly, Alexandra Legge, Lyna Kamintsky, Alon Friedman, Javeria A Hashmi, Steven D Beyea, John Fisk, Antonina Omisade, Cynthia Calkin, Tim Bardouille, Chris Bowen, Kara Matheson, Marvin J Fritzler

Lupus Science & Medicine Jun 2022, 9 (1) e000668; DOI: 10.1136/lupus-2022-000668
Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort
May Y Choi, Ann Elaine Clarke, Katherine Buhler, Michelle Jung, Hannah Mathew, Meifeng Zhang, Francesca S Cardwell, Heather Waldhauser, Marvin J Fritzler

Lupus Science & Medicine Apr 2022, 9 (1) e000667; DOI: 10.1136/lupus-2022-000667
Prevention and partial reversion of the lupus phenotype in ABIN1[D485N] mice by an IRAK4 inhibitor
Tsvetana Petrova, Sambit K Nanda, Cheryl Scudamore, Stephen W Wright, Vikram R Rao, Philip Cohen

Lupus Science & Medicine Nov 2021, 8 (1) e000573; DOI: 10.1136/lupus-2021-000573
Prevalence of systemic lupus erythematosus-related symptoms assessed by using the Connective Tissue Disease Screening Questionnaire in a large population-based cohort
Wietske Lambers, Suzanne Arends, Caroline Roozendaal, Elisabeth Brouwer, Hendrika Bootsma, Johanna Westra, Karina de Leeuw

Lupus Science & Medicine Nov 2021, 8 (1) e000555; DOI: 10.1136/lupus-2021-000555
ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies
Der-Yuan Chen, Yen-Hsiang Huang, Yi-Ming Chen, Jeremy J W Chen, Tsung-Ying Yang, Gee-Chen Chang, Kuo-Tung Tang

Lupus Science & Medicine Nov 2021, 8 (1) e000562; DOI: 10.1136/lupus-2021-000562
Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies
Tammo Brunekreef, Maarten Limper, Rowena Melchers, Linda Mathsson-Alm, Jorge Dias, Imo Hoefer, Saskia Haitjema, Jacob M van Laar, Henny Otten

Lupus Science & Medicine Oct 2021, 8 (1) e000531; DOI: 10.1136/lupus-2021-000531
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases
Yuan Liu, Shiju Chen, Guomei Yang, Bin Wang, Jinying Lan, Fan Dai, Peishi Rao, Puqi Wu, Hongyan Qian, Guixiu Shi

Lupus Science & Medicine Oct 2021, 8 (1) e000523; DOI: 10.1136/lupus-2021-000523
Use of a screening questionnaire for systemic lupus erythematosus among pregnant women in a Mexican population
Luis Lucero-Morales, Juanita Romero-Diaz, Diana Yazmin Copado-Mendoza, María del Carmen Zamora-Medina, Sandra Acevedo-Gallegos, Juan Manuel Gallardo-Gaona, Berenice Velazquez-Torres, Jose Antonio Ramirez-Calvo, Dulce Maria Camarena-Cabrera, Maria Jose Rodriguez-Sibaja

Lupus Science & Medicine Jun 2021, 8 (1) e000486; DOI: 10.1136/lupus-2021-000486

Main menu

Autoantibodies

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoantibodies

Pages